Owner amaxa GmbH

Inventors Christine, Rainer; Lorbach, Elke; Altrogge, Ludger; Klaes, Andrea; Helfrich, Juliana; Turbanski, Tamara; Brosterhus, Helmut; Ortmann, Bodo; Hein, Katharina; Siebenkotten, Gregor; Riemen, Gudula; Schmidt, Hanns-Martin; Gremse, Marion; Males, Tatjana; Lenz, Dietmar

Agent Watermark

Pub. Number AU-B-2002238376

PCT Pub. Number WO2002/055721

Priority 101 00 996.8 10.01.01 DE

Filing date 10 January 2002

Wipo publication date 24 July 2002

Acceptance publication date 10 May 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms